A professor says that Indonesia needs to follow up on India's success in facilitating affordable prices for medicines and medical devices for public.

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment ... chalazion/hordeolum (stye) and punctate keratitis.

The new warnings need to be printed at the start of information leaflets given to both patients ... speak to your doctor who can discuss the risks and benefits of the medication for you, and, if ...

"Patients must be informed about the potential risks, benefits, and outcomes of the procedure, as well as alternatives (including the option of no treatment ... to share this very intimate information ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

The White House’s Office of Management and Budget sent this document to government agencies listing about 2,600 programs that were under review.

As many as two billion people suffer from it — including me. Can science finally bring us relief? Credit...Marcus Schaefer for The New York Times Supported by By Jennifer Kahn Jennifer Kahn is a ...